Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

HLIB Research noted CIMB’s risk-reward profile is balanced and it has a “hold’’ call on the stock with a target price (TP) of RM6.10 a share. The research house added it prefers Public ...

RHB Research made no changes to its earnings forecast on CIMB, maintaining a “buy” call with an unchanged target price of RM9.25 per share. The counter closed 1.12% down at RM7.94 yesterday.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Rights Mar 23, 2010 Mar 25, 2010 Oct 30, 2009 Rights ratio: 1 share for every 16 held at a price of Rs 475.0 Bonus Dec 10, 2009 Dec 11, 2009 Oct 30, 2009 Bonus Ratio: 1 share(s) for every 1 shares ...

Rights Apr 06, 2015-Jan 27, 2015 Rights ratio: 6 share for every 109 held at a price of Rs 450.0 Rights Apr 06, 2015-Jan 27, 2015 Rights ratio: 6 share for every 109 held at a price of Rs 271.0 Rights ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Find insight on UnitedHealth Group, Austrian banks, Standard Chartered, and more in the latest Market Talks covering Financial Services.

ImmuPharma PLC - London-based specialist drug discovery and development company - Notes recent movements in its share price, as it has more than multiplied nearly five times higher in the last month ...